Literature DB >> 16320114

Mouse colon carcinoma cells established for high incidence of experimental hepatic metastasis exhibit accelerated and anchorage-independent growth.

Megumi Morimoto-Tomita1, Yoshimi Ohashi, Azusa Matsubara, Makoto Tsuiji, Tatsuro Irimura.   

Abstract

Highly metastatic variants of mouse colon 38 colon carcinoma cells were established by repeated selection in vivo for liver metastasis and designated as SL4 cells. The SL4 cells formed colonies in the liver of 100% of syngenic mice when injected intrasplenically, while the incidence of liver metastasis was 27% of mice injected with parental cells. The weight of livers, which is an indicator of experimental hepatic metastasis formation, was significantly higher after intrasplenic injection and subsequent splenoctomy with SL4 cells than colon 38 cells. The incidence of hepatic metastasis after intracecal injection of SL4 cells was significantly higher than that of colon 38 cells. The SL4 cells were tested in vitro for their properties. Differences were not detected in the motility and invasive behavior between colon 38 cells and SL4 cells. SL4 cells showed a higher proliferation rate than colon 38 cells under adherent conditions. SL4 cells maintained a capacity to proliferate under non-adherent conditions whereas parental cells did not. SL4 cells should be a useful tool to study the mechanism of hepatic metastasis of colon carcinoma cells and to develop methods to prevent hepatic metastasis.

Entities:  

Mesh:

Year:  2005        PMID: 16320114     DOI: 10.1007/s10585-005-3585-0

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  22 in total

1.  Correlation between the sialylation of cell surface Thomsen-Friedenreich antigen and the metastatic potential of colon carcinoma cells in a mouse model.

Authors:  Y Nemoto-Sasaki; M Mitsuki; M Morimoto-Tomita; A Maeda; M Tsuiji; T Irimura
Journal:  Glycoconj J       Date:  2001 Nov-Dec       Impact factor: 2.916

Review 2.  Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation.

Authors:  L A Liotta; P S Steeg; W G Stetler-Stevenson
Journal:  Cell       Date:  1991-01-25       Impact factor: 41.582

3.  The phagokinetic tracks of 3T3 cells.

Authors:  G Albrecht-Buehler
Journal:  Cell       Date:  1977-06       Impact factor: 41.582

4.  Selection of successive tumour lines for metastasis.

Authors:  I J Fidler
Journal:  Nat New Biol       Date:  1973-04-04

5.  In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinomas implanted into nude mice.

Authors:  K Morikawa; S M Walker; J M Jessup; I J Fidler
Journal:  Cancer Res       Date:  1988-04-01       Impact factor: 12.701

6.  The selection and characterization of an invasive variant of the B16 melanoma.

Authors:  I R Hart
Journal:  Am J Pathol       Date:  1979-12       Impact factor: 4.307

7.  Rapid development of hepatic metastasis with high incidence following orthotopic transplantation of murine colon 38 carcinoma as intact tissue in syngeneic C57BL/6 mice.

Authors:  Y Funahashi; N Koyanagi; J Sonoda; K Kitoh; K Yoshimatsu
Journal:  J Surg Oncol       Date:  1999-06       Impact factor: 3.454

8.  Characterization of metastatic clones derived from a metastatic variant of mouse colon adenocarcinoma 26.

Authors:  T Tsuruo; T Yamori; K Naganuma; S Tsukagoshi; Y Sakurai
Journal:  Cancer Res       Date:  1983-11       Impact factor: 12.701

9.  In vitro selection of murine B16 melanoma variants with enhanced tissue-invasive properties.

Authors:  G Poste; J Doll; I R Hart; I J Fidler
Journal:  Cancer Res       Date:  1980-05       Impact factor: 12.701

10.  Characterization of two highly metastatic variants of Lewis lung carcinoma with different organ specificities.

Authors:  P Brodt
Journal:  Cancer Res       Date:  1986-05       Impact factor: 12.701

View more
  20 in total

Review 1.  Colorectal cancer models for novel drug discovery.

Authors:  Daniel Golovko; Dmitriy Kedrin; Ömer H Yilmaz; Jatin Roper
Journal:  Expert Opin Drug Discov       Date:  2015-08-21       Impact factor: 6.098

2.  Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastases.

Authors:  Nuh N Rahbari; Dmitriy Kedrin; Joao Incio; Hao Liu; William W Ho; Hadi T Nia; Christina M Edrich; Keehoon Jung; Julien Daubriac; Ivy Chen; Takahiro Heishi; John D Martin; Yuhui Huang; Nir Maimon; Christoph Reissfelder; Jurgen Weitz; Yves Boucher; Jeffrey W Clark; Alan J Grodzinsky; Dan G Duda; Rakesh K Jain; Dai Fukumura
Journal:  Sci Transl Med       Date:  2016-10-12       Impact factor: 17.956

3.  The innate immune receptor Dectin-2 mediates the phagocytosis of cancer cells by Kupffer cells for the suppression of liver metastasis.

Authors:  Yoshitaka Kimura; Asuka Inoue; Sho Hangai; Shinobu Saijo; Hideo Negishi; Junko Nishio; Sho Yamasaki; Yoichiro Iwakura; Hideyuki Yanai; Tadatsugu Taniguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-21       Impact factor: 11.205

4.  Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy.

Authors:  Keehoon Jung; Takahiro Heishi; Omar F Khan; Piotr S Kowalski; Joao Incio; Nuh N Rahbari; Euiheon Chung; Jeffrey W Clark; Christopher G Willett; Andrew D Luster; Seok Hyun Yun; Robert Langer; Daniel G Anderson; Timothy P Padera; Rakesh K Jain; Dai Fukumura
Journal:  J Clin Invest       Date:  2017-07-10       Impact factor: 14.808

5.  Liver acid sphingomyelinase inhibits growth of metastatic colon cancer.

Authors:  Yosuke Osawa; Atsushi Suetsugu; Rie Matsushima-Nishiwaki; Ichiro Yasuda; Toshiji Saibara; Hisataka Moriwaki; Mitsuru Seishima; Osamu Kozawa
Journal:  J Clin Invest       Date:  2013-01-09       Impact factor: 14.808

6.  CD133(+) single cell-derived progenies of colorectal cancer cell line SW480 with different invasive and metastatic potential.

Authors:  Guangqiu Li; Chao Liu; Jian Yuan; Xiaoqin Xiao; Na Tang; Junmei Hao; Hongwei Wang; Xiuwu Bian; Yongjian Deng; Yanqing Ding
Journal:  Clin Exp Metastasis       Date:  2010-07-09       Impact factor: 5.150

7.  Complement 5a Enhances Hepatic Metastases of Colon Cancer via Monocyte Chemoattractant Protein-1-mediated Inflammatory Cell Infiltration.

Authors:  Chunmei Piao; Lun Cai; Shulan Qiu; Lixin Jia; Wenchao Song; Jie Du
Journal:  J Biol Chem       Date:  2015-03-04       Impact factor: 5.157

8.  A highly bone marrow metastatic murine breast cancer model established through in vivo selection exhibits enhanced anchorage-independent growth and cell migration mediated by ICAM-1.

Authors:  Munehisa Takahashi; Mutsuo Furihata; Nobuyoshi Akimitsu; Morihiro Watanabe; Sunil Kaul; Noboru Yumoto; Tomoko Okada
Journal:  Clin Exp Metastasis       Date:  2008-03-14       Impact factor: 5.150

9.  AMP-activated protein kinase α2 protects against liver injury from metastasized tumors via reduced glucose deprivation-induced oxidative stress.

Authors:  Shu-Lan Qiu; Zhi-Cheng Xiao; Chun-Mei Piao; Ying-Lin Xian; Li-Xin Jia; Yong-Fen Qi; Jia-Huai Han; You-Yi Zhang; Jie Du
Journal:  J Biol Chem       Date:  2014-02-10       Impact factor: 5.157

10.  Loss of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 3 and reduced O-glycosylation in colon carcinoma cells selected for hepatic metastasis.

Authors:  Kentaro Kato; Hideyuki Takeuchi; Akira Kanoh; Naoki Miyahara; Yoko Nemoto-Sasaki; Megumi Morimoto-Tomita; Azusa Matsubara; Yoshimi Ohashi; Michihiko Waki; Katsuaki Usami; Ulla Mandel; Henrik Clausen; Nobuaki Higashi; Tatsuro Irimura
Journal:  Glycoconj J       Date:  2010-02       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.